NCT03387293 is a NA clinical trial of LGI-LII Breakfast in Pediatric Obesity, sponsored by TC Erciyes University.

Who is sponsoring NCT03387293?

NCT03387293 is sponsored by TC Erciyes University.

What drugs are being tested in NCT03387293?

Interventions in NCT03387293: LGI-LII Breakfast, LGI-HII Breakfast.

What condition does NCT03387293 study?

NCT03387293 studies Pediatric Obesity.

Is NCT03387293 still recruiting?

NCT03387293 is currently completed. Last updated 2 January 2018.

Last reviewed 2018-01-02 · How we verify

NCT03387293

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Food Insulin Index on Metabolic Parameters in Obese Adolescents

Completed NA Last updated 2 January 2018

What this trial tests

NA trial testing LGI-LII Breakfast in Pediatric Obesity in 22 participants. Completed in 1 May 2017.

Timeline

1 November 2016

Primary endpoint
1 March 2017

1 May 2017

Quick facts

Lead sponsor	TC Erciyes University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	screening
Enrollment	22
Start date	1 November 2016
Primary completion	1 March 2017
Estimated completion	1 May 2017

Drugs / interventions tested

LGI-LII Breakfast
LGI-HII Breakfast

Conditions studied

Pediatric Obesity — all drugs for Pediatric Obesity →

Sponsor

TC Erciyes University

Who can join

Adults 12 to 18, any sex, with Pediatric Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to determine the effect of food insulin index (FII) on metabolic parameters and appetite in obese adolescents with insulin resistance. A randomized, single-blind and crossover trial included 15 obese adolescents aged 12-18 years with insulin resistance. All participants were submitted two different breakfasts: low glycemic index, low insulin index (LGI-LII) and low glycemic index, high insulin index (LGI-HII), with a 1-week washout period between meals. At time 0 (just before breakfast), 15, 30, 45, 60, 90, 120, 180 and 240 minutes after the meal, serum glucose, insulin and c-peptide levels were measured and appetite was evaluated by visual analog scale. At the end of four hours, participants were served ad libitum lunch meal. Then, the foods eaten at lunch were recorded and their energy and nutrient analysis was calculated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pediatric Obesity

Currently open trials in the same condition.

NCT06565455 — Growing Healthy Children and Families in Rural Arkansas · NA · recruiting
NCT07342855 — Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program · NA · recruiting
NCT07095166 — Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME) · NA · recruiting
NCT07229508 — Developmental Trajectories of Reinforcer Pathology and Childhood Obesity · recruiting
NCT06572345 — Low EnerGy DiEt iN Adolescents With Obesity and Type 2 Diabetes: The LEGEND Study · NA · recruiting

Other TC Erciyes University trials

Trials by the same sponsor.

NCT07007858 — Effects of High-Velocity Passive Stretch on Spasticity, Function, and Muscle Structure in Spastic CP Children · NA · enrolling by invitation
NCT07529964 — MMP-2/3 and Periapical Healing Outcomes · not yet recruiting
NCT07526831 — Comparison of the Analgesic Efficacy of Adductor Canal Block and Combined Adductor Canal Block Plus IPACK Block in Knee · recruiting
NCT07371806 — EFFETCS OF MİNDFULNESS-BASED STRESS REDUCTION İN WOMEN WİTH CORONARY ARTERY DİSEASE · NA · not yet recruiting
NCT07499947 — Predicting Spinal Hypotension in Cesarean Section · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03387293 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by TC Erciyes University
Last refreshed: 2 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03387293.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing